Isoliquiritigenin Induces Apoptosis and Inhibits Xenograft Tumor Growth of Human Lung Cancer Cells by Targeting Both Wild Type and L858R/T790M Mutant EGFR

The PI3k inhibitors: new hopes in the battle against advanced NSCLC

(2014) Paola Sacco   Frontiers in Bioscience-Landmark

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies

(2013) S. Carrera et al.   Clinical & Translational Oncology

Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells

(2013) Kai-Lee Wang et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC

(2013) A.G. Pallis et al.   LUNG CANCER

Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway

(2013) Zhiyu Wang et al.   PLoS One

Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer

(2013) Ying Li et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Isoliquiritigenin treatment induces apoptosis by increasing intracellular ROS levels in HeLa cells

(2012) Xuan Yuan et al.   JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH

Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling

(2012) Xiangzheng Chen et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

A Novel Classification of Lung Cancer into Molecular Subtypes

(2012) Lisandra West et al.   PLoS One

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

(2010) Alexa B. Turke et al.   CANCER CELL

Cancer Chemopreventive Activity and Metabolism of Isoliquiritigenin, a Compound Found in Licorice

(2010) M. Cuendet et al.   Cancer Prevention Research

MET signalling: principles and functions in development, organ regeneration and cancer

(2010) Livio Trusolino et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

(2009) Wenjun Zhou et al.   NATURE

Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors

(2009) T John et al.   ONCOGENE

Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-κB in RAW 264.7 macrophages

(2008) Ji-Yeon Kim et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling

(2008) Gyoo Taik Kwon et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond

(2008) Marc Ladanyi et al.   MODERN PATHOLOGY